SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-011040
Filing Date
2023-04-05
Accepted
2023-04-05 16:28:15
Documents
1
Period of Report
2023-04-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4158
  Complete submission text file 0001493152-23-011040.txt   5755
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O STAR SCIENTIFIC, INC. 7475 WISCONSIN AVENUE, SUITE 850 BETHESDA MD 20814
Business Address
Chapman Christopher C JR (Reporting) CIK: 0001340428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36268 | Film No.: 23802916